Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.49 EUR | +0.68% |
|
-4.52% | -9.20% |
06-06 | I-Mab Appoints Phillip Dennis as Chief Medical Officer | CI |
06-05 | I-Mab Collaborates With Bristol-Myers to Evaluate Givastomig in Combination Study for Gastric, Esophageal Cancers | MT |
- Stock Market
- Equities
- IMAB Stock
- 0VY Stock
- News I-Mab
- Analyst Reco.